Showing results (11-20 of 280) with videos related to
Sort By:
Pageof 28
BMC Medical Genomics|October 17, 2015
Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12Amanda R Campbell, Kelly Regan, Neela Bhave, et al.Journal of Surgical Oncology|October 14, 2015
Surgical management of ovarian carcinoma metastatic to the breast and axilla: A role for metastasectomy?Kara K Rossfeld, William E CarsonAnnals of the New York Academy of Sciences|January 16, 2010
Immune modulation with interleukin-21Neela S Bhave, William E CarsonJournal for Immunotherapy of Cancer|May 16, 2014
Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancerRobert Wesolowski, Joseph Markowitz, William E CarsonCancer Immunology, Immunotherapy : CII|April 5, 2021
Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironmentLogan Good, Brooke Benner, William E CarsonTransactions on Machine Learning Research|January 8, 2024
Estimating Potential Outcome Distributions with Collaborating Causal NetworksTianhui Zhou, William E Carson, David CarlsonThe Journal of Biological Chemistry|September 30, 2006
Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformationNidhi Sharma, Cynthia Timmers, Prashant Trikha, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cellsJulie M Roda, Robin Parihar, William E CarsonClinical Case Reports|December 20, 2018
Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphomaKristen M Quinn, Gary Tozbikian, William E CarsonThe Journal of Clinical Investigation|October 9, 2002
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cellsRobin Parihar, Julie Dierksheide, Yan Hu, et al.Pageof 28